Yann-Lii Leu Selected Research

propolin G

1/2022

Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yann-Lii Leu Research Topics

Disease

16	Neoplasms (Cancer) 05/2022 - 04/2007
16	Inflammation (Inflammations) 02/2022 - 05/2006
9	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2021 - 06/2009
5	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 01/2015
5	Infections 01/2017 - 01/2007
4	Liver Neoplasms (Liver Cancer) 09/2021 - 12/2019
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 02/2020
3	Body Weight (Weight, Body) 02/2022 - 12/2019
3	Insulin Resistance 01/2021 - 01/2019
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2018
3	Obesity 01/2021 - 01/2019
3	Atherosclerosis 03/2020 - 10/2011
3	Fibrosis (Cirrhosis) 01/2019 - 02/2012
2	Breast Neoplasms (Breast Cancer) 09/2021 - 04/2007
2	Squamous Cell Carcinoma of Head and Neck 09/2021 - 01/2019
2	Hyperplasia 03/2020 - 01/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2017 - 07/2015
2	Hypertension (High Blood Pressure) 08/2015 - 06/2011
2	Skin Diseases (Skin Disease) 01/2013 - 02/2012
1	Carcinogenesis 02/2022
1	Colitis-Associated Neoplasms 02/2022
1	Dysbiosis 02/2022
1	Colitis 02/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Dermatitis 10/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Atherosclerotic Plaque (Atheroma) 03/2020
1	Endotoxemia 12/2019
1	Fatty Liver 12/2019
1	Chronic Disease (Chronic Diseases) 12/2019

Drug/Important Bio-Agent (IBA)

6	Indigo Carmine (Indigo Blue)IBA 12/2019 - 06/2009
5	Pharmaceutical PreparationsIBA 01/2021 - 05/2006
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2007
4	corylinIBA 02/2022 - 01/2018
4	hydroxygenkwaninIBA 09/2021 - 12/2019
4	viscolinIBA 01/2016 - 11/2006
3	Imiquimod (Aldara)FDA LinkGeneric 10/2021 - 11/2018
3	FlavonoidsIBA 01/2021 - 11/2017
3	LipidsIBA 03/2020 - 02/2013
3	Proteins (Proteins, Gene)FDA Link 12/2019 - 02/2012
2	AntioxidantsIBA 01/2022 - 07/2009
2	Insulin (Novolin)FDA Link 01/2022 - 12/2019
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2021 - 12/2015
2	Biological ProductsIBA 08/2021 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 12/2020
2	ApolipoproteinsIBA 03/2020 - 02/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020 - 01/2012
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 01/2020
2	NF-kappa B (NF-kB)IBA 02/2019 - 01/2012
2	Becaplermin (PDGF-BB)FDA Link 02/2019 - 01/2016
2	Long Noncoding RNAIBA 01/2019 - 01/2018
2	growth arrest specific transcript 5IBA 01/2019 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2007
2	Qingdai compoundIBA 03/2012 - 08/2009
1	Phosphotransferases (Kinase)IBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	Dextrans (Dextran)FDA Link 02/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2022
1	VimentinIBA 01/2022
1	Propolis (Bee Bread)IBA 01/2022
1	propolin GIBA 01/2022
1	Glycogen Synthase KinasesIBA 01/2022
1	Endothelial Growth FactorsIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	Furocoumarins (Furanocoumarins)IBA 10/2021
1	imperatorinIBA 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021
1	palbociclibIBA 09/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2021
1	bavachininIBA 08/2021
1	flavanoneIBA 08/2021
1	QuercetinIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	brigatinibIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 03/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	magnololIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 12/2019
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2019
1	LigandsIBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Interleukin-22 (IL-22)IBA 12/2019
1	Interleukin-10 (Interleukin 10)IBA 12/2019
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2019
1	diallyl disulfide (diallyl disulphide)IBA 10/2019
1	p38 Mitogen-Activated Protein KinasesIBA 02/2019
1	MelatoninIBA 02/2019

Therapy/Procedure

6	Therapeutics 10/2021 - 01/2015
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2021 - 01/2011
2	Drug Therapy (Chemotherapy) 09/2021 - 10/2019
2	Radiotherapy 09/2021 - 10/2019
1	Adjuvant Chemotherapy 09/2021
1	Chemoprevention 08/2021